KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Clinical Trials Innovation

Ask the Experts: 5 of the most exciting developments in clinical trials

With new technologies, partnerships and strategies developing in clinical trials all the time, the industry is changing at a rapid rate. Over the last six months we have spoken with dozens of clinical trial professionals and asked them what they think the most exciting developments are. Here we have gathered six of the most common answers we got.

1) Real-time data management

“The use of Apps and tablets for collection of data, to improve timing and quality of trials.” Isabella Salerio, Clinical Operation, Zambon

“Improved system interfaces leading to real-time reporting of clinical trial operational status at your fingertips – really supporting management and oversight of trials.” Julianne Hull, CEO, WenStar Enterprises

2) Electronic Forms

“Standardized electronic patients’ notes developed to use for sites across the globe to put dates in immediately and transfer them in eCRFs. Online patient recruitment portals are also a great support for the sites” Helena Sigal, Founder, SIGAL SMS

3) Patient centricity

“I really think that the increasing voice of the patient is exciting. More and more companies are making the effort to truly listen to what exactly it is that patients want - and so are the Regulators.” Diane Driver, Head Outsourcing Contracts & Strategic Partnerships, UCB

4) Strategic partnerships

“Strategic partnering allows for more optimal interfacing between sponsors and service providers. This in turn allows for faster identification and resolution of problems and safety issues.” David Shalhevet, Associate Director, Senior Clinical Trial Manager, Teva Pharmaceutical

5) Risk management

“There are some really exciting changes coming with regard to the management of risk. I am optimistic that these will mature within the next 12-24 months to offer some exciting choices.” Mireille Zerola , Risk Based Monitoring Implementation Project Lead, Boehringer Ingelheim

Get articles like this by email